WAO News and Notes - Announcing Events and Programs
Volume 5, Issue 2
February 2008
Upcoming WAO Meetings and Events

world allergy forum

You Are Invited to Attend . . .
World Allergy Forum (WAF)

WAF Symposium: "The Application of Monoclonal Therapies and Therapeutics to Asthma and Allergy"

2008 AAAAI Annual Meeting
Sunday, 16 March 2008
10:45 a.m. - 12:00 p.m.
Philadelphia, PA, USA

G. Walter Canonica
Thomas B. Casale

Designer Drug Design: How are Monoclonal Antibodies Made in 2008?
Shyam S. Mohapatra

Adverse Effects in the Application of Biotechnology
Jean Bousquet

The Future Application of Monoclonal Antibodies to Asthma and Allergy
Stephen T. Holgate

World Allergy Forum is supported through an unrestricted educational grant from:

Upcoming Worldwide Allergy Meetings

German Society for Allergology and Clinical Immunology
Mainzer Allergy Workshop

7-8 March 2008
Clinic for Dermatology, Johannes Gutenberg-University

American Academy of Allergy, Asthma & Immunology (AAAAI)
64th Annual Meeting

14-18 March 2008
Philadelphia, PA, USA

TIGERS Meeting
The 2nd International Gastrointestinal Eosinophil Research Symposium

14 March 2008
Philadelphia, PA, USA

Dutch Society of Allergy
Annual Meeting

21 March 2008

Malaysian Society of Allergy and Immunology
Ninth Malaysian Congress and Exhibition on Allergy and Immunology

28-30 March 2008
Kuala Lumpur, Malaysia

wao logo

The World Allergy Organization's mission is to be a global resource and advocate in the field of allergy, advancing excellence in clinical care through education, research and training as a world-wide alliance of allergy and clinical immunology societies. Visit us on the Web at www.worldallergy.org

World Allergy Organization (WAO)
555 E. Wells Street, Suite 1100
Milwaukee, WI 53202-3823
Email: info@worldallergy.org

You have received this message because you are a member of a WAO Member Society, you have subscribed for the monthly e-letter or had previous contact with the World Allergy Organization. If you would prefer not to receive further messages from WAO, please reply to this message with REMOVE in the subject line.

Made possible through an unrestricted educational grant from Novartis.